IL17A and psoriasis: The current work demonstrated (Figure 4) that the fabricated gelatin patch presented suitable morphology (the size of nanofiber and porous structure) to support the topical release of anti-TNFα and anti-IL-17α suggesting future developments to adapt their application for the treatment of psoriasis.